Encorafenib
Encorafenib | |
---|---|
Term | Encorafenib |
Short definition | Encorafenib (EN-kor-A-feh-Feder) A drug used with cetuximab to treat certain types of colon cancer and with binimetinib to treat certain types of melanoma. It is used in patients whose cancer has a certain mutation (change) in the BRAF gene. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Encorafenib - (pronounced) (EN-kor-A-feh-Feder) A drug used with cetuximab to treat certain types of colon cancer and with binimetinib to treat certain types of melanoma. It is used in patients whose cancer has a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Encorafenib blocks certain proteins made by the mutation in the BRAF gene, which can help stop cancer cells from growing. It's a kind of kinase inhibitor. Also called Braftovi
External links
- Medical encyclopedia article on Encorafenib
- Wikipedia's article - Encorafenib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski